Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema Types I and II”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Study completedNCT06467084
What this trial is testing

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 36
Not applicableStudy completedNCT04130191
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Who this might be right for
Hereditary Angioedema (HAE)
Shire 140
Large-scale testing (Phase 3)Study completedNCT02586805
What this trial is testing

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 125
Not applicableActive Not RecruitingNCT05469789
What this trial is testing

Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 50
Large-scale testing (Phase 3)Study completedNCT06343779
What this trial is testing

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+11 more
Pharvaris Netherlands B.V. 134
Large-scale testing (Phase 3)Study completedNCT02316353
What this trial is testing

Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 126
Not applicableStudy completedNCT04861090
What this trial is testing

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 207
Not applicableEnded earlyNCT04091113
What this trial is testing

Hereditary Angioedema Kininogen Assay

Who this might be right for
Hereditary Angioedema
CENTOGENE GmbH Rostock 59
Large-scale testing (Phase 3)Study completedNCT03472040
What this trial is testing

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHAEProphylaxis
BioCryst Pharmaceuticals 387
Not applicableUnknownNCT03828279
What this trial is testing

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II

Who this might be right for
Hereditary Angioedema Type I and II
HAE Global Registry Foundation 220
Large-scale testing (Phase 3)Study completedNCT05259917
What this trial is testing

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Not applicableApproved For MarketingNCT06628713
What this trial is testing

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Testing effectiveness (Phase 2)Study completedNCT00119431
What this trial is testing

Kinetics, Efficacy and Safety of C1-Esteraseremmer-N

Who this might be right for
Hereditary Angioedema Type IAngioneurotic Edema
Prothya Biosolutions 12
Testing effectiveness (Phase 2)Study completedNCT04618211
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 74
Testing effectiveness (Phase 2)Study completedNCT05047185
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34
Early research (Phase 1)Study completedNCT01760343
What this trial is testing

Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 16
Not applicableStudy completedNCT03029728
What this trial is testing

Biomarker for Hereditary AngioEdema Disease

Who this might be right for
C1 Esterase Inhibitor DeficiencyAngio EdemaC4 Deficiency+5 more
CENTOGENE GmbH Rostock 42
Testing effectiveness (Phase 2)Study completedNCT01576523
What this trial is testing

Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 18
Large-scale testing (Phase 3)Study completedNCT00912093
What this trial is testing

Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Who this might be right for
Hereditary Angioedema
Shire 98
Load More Results